TY - JOUR
T1 - Molecular Characterization of the ClpC AAA+ ATPase in the Biology of Chlamydia trachomatis
AU - Pan, Stefan
AU - Jensen, Aaron A.
AU - Wood, Nicholas A.
AU - Henrichfreise, Beate
AU - Brötz-Oesterhelt, Heike
AU - Fisher, Derek J.
AU - Sass, Peter
AU - Ouellette, Scot P.
N1 - Funding Information:
We thank H. Caldwell (NIH/NIAID) for eukaryotic cell lines, T. Hackstadt (RML/NIAID) for the pBOMB4-Tet::L2 plasmid and the rabbit anti-HctB antibody, I. Clarke (University of Southampton) for the plasmidless strain of C. trachomatis serovar L2, and Lucas Struble in G. Borgstahl’s lab (UNMC) for his help purifying recombinant ClpC protein for antibody production. We further thank Paul R. Thompson (UMass Chan Medical School) for providing anti-P-Arg antibodies and Tim Clausen (IMP Vienna) for sharing the plasmid encoding G. stearothermophilus McsB-6xHis. This project was supported by an NIAID/National Institutes of Health awards (1R56AI146062 to S.P.O. and 1R01AI170688 to S.P.O. and D.J.F.) and university funds to D.J.F. We further appreciate funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): TRR 261, project ID 398967434 to P.S., H.B.O., and B.H., as well as support by infrastructural funding from Cluster of Excellence EXC 2124 Controlling Microbes to Fight Infections, project ID 390838134. We acknowledge support from the Open Access Publication Fund of the University of Tübingen.
Funding Information:
This project was supported by an NIAID/National Institutes of Health awards (1R56AI146062 to S.P.O. and 1R01AI170688 to S.P.O. and D.J.F.) and university funds to D.J.F. We further appreciate funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): TRR 261, project ID 398967434 to P.S., H.B.O., and B.H., as well as support by infrastructural funding from Cluster of Excellence EXC 2124 Controlling Microbes to Fight Infections, project ID 390838134. We acknowledge support from the Open Access Publication Fund of the University of Tübingen.
Publisher Copyright:
Copyright © 2023 Pan et al.
PY - 2023/3
Y1 - 2023/3
N2 - Bacterial AAA1 unfoldases are crucial for bacterial physiology by recognizing specific substrates and, typically, unfolding them for degradation by a proteolytic component. The caseinolytic protease (Clp) system is one example where a hexameric unfoldase (e.g., ClpC) interacts with the tetradecameric proteolytic core ClpP. Unfoldases can have both ClpP-dependent and ClpP-independent roles in protein homeostasis, development, virulence, and cell differentiation. ClpC is an unfoldase predominantly found in Gram-positive bacteria and mycobacteria. Intriguingly, the obligate intracellular Gram-negative pathogen Chlamydia, an organism with a highly reduced genome, also encodes a ClpC ortholog, implying an important function for ClpC in chlamydial physiology. Here, we used a combination of in vitro and cell culture approaches to gain insight into the function of chlamydial ClpC. ClpC exhibits intrinsic ATPase and chaperone activities, with a primary role for the Walker B motif in the first nucleotide binding domain (NBD1). Furthermore, ClpC binds ClpP1P2 complexes via ClpP2 to form the functional protease ClpCP2P1 in vitro, which degraded arginine-phosphorylated b-casein. Cell culture experiments confirmed that higher order complexes of ClpC are present in chlamydial cells. Importantly, these data further revealed severe negative effects of both overexpression and depletion of ClpC in Chlamydia as revealed by a significant reduction in chlamydial growth. Here, again, NBD1 was critical for ClpC function. Hence, we provide the first mechanistic insight into the molecular and cellular function of chlamydial ClpC, which supports its essentiality in Chlamydia. ClpC is, therefore, a potential novel target for the development of antichlamydial agents. IMPORTANCE Chlamydia trachomatis is an obligate intracellular pathogen and the world's leading cause of preventable infectious blindness and bacterial sexually transmitted infections. Due to the high prevalence of chlamydial infections along with negative effects of current broad-spectrum treatment strategies, new antichlamydial agents with novel targets are desperately needed. In this context, bacterial Clp proteases have emerged as promising new antibiotic targets, since they often play central roles in bacterial physiology and, for some bacterial species, are even essential for survival. Here, we report on the chlamydial AAA1 unfoldase ClpC, its functional reconstitution and characterization, individually and as part of the ClpCP2P1 protease, and establish an essential role for ClpC in chlamydial growth and intracellular development, thereby identifying ClpC as a potential target for antichlamydial compounds.
AB - Bacterial AAA1 unfoldases are crucial for bacterial physiology by recognizing specific substrates and, typically, unfolding them for degradation by a proteolytic component. The caseinolytic protease (Clp) system is one example where a hexameric unfoldase (e.g., ClpC) interacts with the tetradecameric proteolytic core ClpP. Unfoldases can have both ClpP-dependent and ClpP-independent roles in protein homeostasis, development, virulence, and cell differentiation. ClpC is an unfoldase predominantly found in Gram-positive bacteria and mycobacteria. Intriguingly, the obligate intracellular Gram-negative pathogen Chlamydia, an organism with a highly reduced genome, also encodes a ClpC ortholog, implying an important function for ClpC in chlamydial physiology. Here, we used a combination of in vitro and cell culture approaches to gain insight into the function of chlamydial ClpC. ClpC exhibits intrinsic ATPase and chaperone activities, with a primary role for the Walker B motif in the first nucleotide binding domain (NBD1). Furthermore, ClpC binds ClpP1P2 complexes via ClpP2 to form the functional protease ClpCP2P1 in vitro, which degraded arginine-phosphorylated b-casein. Cell culture experiments confirmed that higher order complexes of ClpC are present in chlamydial cells. Importantly, these data further revealed severe negative effects of both overexpression and depletion of ClpC in Chlamydia as revealed by a significant reduction in chlamydial growth. Here, again, NBD1 was critical for ClpC function. Hence, we provide the first mechanistic insight into the molecular and cellular function of chlamydial ClpC, which supports its essentiality in Chlamydia. ClpC is, therefore, a potential novel target for the development of antichlamydial agents. IMPORTANCE Chlamydia trachomatis is an obligate intracellular pathogen and the world's leading cause of preventable infectious blindness and bacterial sexually transmitted infections. Due to the high prevalence of chlamydial infections along with negative effects of current broad-spectrum treatment strategies, new antichlamydial agents with novel targets are desperately needed. In this context, bacterial Clp proteases have emerged as promising new antibiotic targets, since they often play central roles in bacterial physiology and, for some bacterial species, are even essential for survival. Here, we report on the chlamydial AAA1 unfoldase ClpC, its functional reconstitution and characterization, individually and as part of the ClpCP2P1 protease, and establish an essential role for ClpC in chlamydial growth and intracellular development, thereby identifying ClpC as a potential target for antichlamydial compounds.
KW - AAA1 ATPase
KW - Chlamydia
KW - Clp protease
KW - ClpC
KW - ClpP
KW - development
KW - differentiation
UR - http://www.scopus.com/inward/record.url?scp=85153897558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85153897558&partnerID=8YFLogxK
U2 - 10.1128/mbio.00075-23
DO - 10.1128/mbio.00075-23
M3 - Article
C2 - 36975997
AN - SCOPUS:85153897558
SN - 2161-2129
VL - 14
JO - mBio
JF - mBio
IS - 2
ER -